Gold Nanoparticles Open New Horizons for Treating Incurable Brain Diseases

An Italian research team has achieved a groundbreaking scientific milestone by developing a gold nanoparticle–based therapy that targets complex brain diseases such as Alzheimer’s and bipolar disorder. This discovery could mark a major turning point in modern neurological medicine.

According to a report published in Advanced Materials, the scientists successfully engineered ultra-fine gold particles with a diameter of no more than two nanometers, coated with glutathione and enhanced with lithium ions. Administered as a nasal spray, the treatment can reach brain cells directly, ensuring high therapeutic efficacy while preventing excessive lithium levels in the blood—thus reducing the risk of side effects on the kidneys and thyroid gland.

Laboratory tests on mice showed that this technique inhibits the activity of the enzyme “GSK-3β” in the hippocampus — the brain region responsible for memory and learning. This suggests the potential to improve cognitive functions and slow neuronal degeneration in patients.

The research team has officially filed a patent for this innovation, paving the way for clinical trials and human safety testing after the promising results observed in preclinical studies.

This breakthrough could represent a global medical revolution, turning gold — once valued only as a precious metal — into a powerful therapeutic tool capable of helping millions of people affected by neurodegenerative brain diseases worldwide.